BeiGene is scrapping ociperlimab over a disappointing phase 3 outlook two years after Novartis handed back the anti-TIGIT ...
Two phase 2 trials with different selective TYK2 inhibitors produce high rates of efficacy in moderate to severe plaque ...
Toxicity information from phase 3 oncology clinical trials often is incomplete and interpreted in ways that minimize its ...
Neurona Therapeutics has circled up $102 million to push its off-the-shelf cell therapy for epilepsy through phase 3 testing.
OSHKOSH – The community was split down the middle on the Oshkosh Area School District’s facilities plan. The $197.8 million ...
Giant-cell arteritis is a systemic vasculitis with limited treatment options. The efficacy and safety of upadacitinib — a ...
Q4 2024 Management View CEO George Lasezkay highlighted the company's progress in advancing its suprachoroidal delivery platform, noting over 15,000 suprachoroidal injections performed to date. He ...
Pharmaceutical announced that the Phase 3 PEGASUS trial evaluating Palynziq met its primary efficacy endpoint, demonstrating a ...
Game Rant on MSN9d
Nintendo Reportedly Has 'Three-Phase' Launch Plan for the Switch 2According to insider reports, Nintendo is planning a three-phase launch strategy for the Nintendo Switch 2 and its initial ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback